MedTrace Logo

How Body Awareness Promotes Mental Health During Yoga and Physical Exercise

NCT03553745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2021-02-25

No results posted yet for this study

Summary

The integrity of interoceptive networks is linked to resilience against depressive symptoms, whereas degradation of these networks is linked to apathy and deficits in emotion processing. The goal of this study is to compare two major styles of yoga and cardiovascular exercise through a 10-week training program to promote interoceptive awareness. The researchers hypothesize that improvement in affective symptomatology will be correlated with better interoceptive development. Changes in mood related symptoms and interoception will be assessed at baseline, week 12 and week 14, in a cohort of adults aged 18-55.

Conditions

  • Negative Thoughts
  • Mild Depression
  • Stress

Interventions

BEHAVIORAL

Gentle Yoga Intervention

10-week exercise program structured around gentle yoga practice.

BEHAVIORAL

Rigorous Yoga Intervention

10-week exercise program structured around rigorous yoga practice.

BEHAVIORAL

Physical Exercise Intervention

10-week exercise program structured around cardiovascular exercise.

Sponsors & Collaborators

  • Yoga Science Foundation

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Sara Lazar, PhD · Massachusetts General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2021-02-23
Completion
2021-02-23

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03553745 on ClinicalTrials.gov